Pathophysiology-based subphenotyping of individuals at elevated risk for type 2 diabetes
View ORCID ProfileRobert Wagner, Martin Heni, Adam G. Tabak, Jürgen Machann, Fritz Schick, Elko Randrianarisoa, Martin Hrabě de Angelis, Andreas L. Birkenfeld, Norbert Stefan, Andreas Peter, Hans-Ulrich Häring, Andreas Fritsche
doi: https://doi.org/10.1101/2020.10.12.20210062
Robert Wagner
1Institute for Diabetes Research and Metabolic Diseases of the Helmholtz Center Munich at the University of Tübingen, Germany
2German Center for Diabetes Research (DZD e.V.), Neuherberg, Germany
3Department of Internal Medicine, Division of Diabetology, Endocrinology and Nephrology, Eberhard-Karls University Tübingen, Germany
Martin Heni
1Institute for Diabetes Research and Metabolic Diseases of the Helmholtz Center Munich at the University of Tübingen, Germany
2German Center for Diabetes Research (DZD e.V.), Neuherberg, Germany
3Department of Internal Medicine, Division of Diabetology, Endocrinology and Nephrology, Eberhard-Karls University Tübingen, Germany
Adam G. Tabak
4Department of Epidemiology and Public Health, University College London, London, United Kingdom
5Department of Internal Medicine and Oncology, Semmelweis University Faculty of Medicine, Budapest, Hungary
6Department of Public Health, Semmelweis University Faculty of Medicine, Budapest, Hungary
Jürgen Machann
2German Center for Diabetes Research (DZD e.V.), Neuherberg, Germany
7University Department of Radiology, Section on Experimental Radiology, Eberhard-Karls University Tübingen, Germany
Fritz Schick
2German Center for Diabetes Research (DZD e.V.), Neuherberg, Germany
7University Department of Radiology, Section on Experimental Radiology, Eberhard-Karls University Tübingen, Germany
Elko Randrianarisoa
1Institute for Diabetes Research and Metabolic Diseases of the Helmholtz Center Munich at the University of Tübingen, Germany
2German Center for Diabetes Research (DZD e.V.), Neuherberg, Germany
Martin Hrabě de Angelis
2German Center for Diabetes Research (DZD e.V.), Neuherberg, Germany
8Helmholtz Zentrum München, Institute of Experimental Genetics and German Mouse Clinic, Neuherberg, Germany
9Chair of Experimental Genetics, Centre of Life and Food Sciences, Weihenstephan, Technische Universität München, Freising, Germany
Andreas L. Birkenfeld
1Institute for Diabetes Research and Metabolic Diseases of the Helmholtz Center Munich at the University of Tübingen, Germany
2German Center for Diabetes Research (DZD e.V.), Neuherberg, Germany
3Department of Internal Medicine, Division of Diabetology, Endocrinology and Nephrology, Eberhard-Karls University Tübingen, Germany
Norbert Stefan
1Institute for Diabetes Research and Metabolic Diseases of the Helmholtz Center Munich at the University of Tübingen, Germany
2German Center for Diabetes Research (DZD e.V.), Neuherberg, Germany
3Department of Internal Medicine, Division of Diabetology, Endocrinology and Nephrology, Eberhard-Karls University Tübingen, Germany
10Department of Pediatrics, Harvard Medical School, Boston, MA, USA
Andreas Peter
1Institute for Diabetes Research and Metabolic Diseases of the Helmholtz Center Munich at the University of Tübingen, Germany
2German Center for Diabetes Research (DZD e.V.), Neuherberg, Germany
11Institute for Clinical Chemistry and Pathobiochemistry, Department for Diagnostic Laboratory Medicine, University Hospital of Tübingen, Germany
Hans-Ulrich Häring
1Institute for Diabetes Research and Metabolic Diseases of the Helmholtz Center Munich at the University of Tübingen, Germany
2German Center for Diabetes Research (DZD e.V.), Neuherberg, Germany
Andreas Fritsche
1Institute for Diabetes Research and Metabolic Diseases of the Helmholtz Center Munich at the University of Tübingen, Germany
2German Center for Diabetes Research (DZD e.V.), Neuherberg, Germany
3Department of Internal Medicine, Division of Diabetology, Endocrinology and Nephrology, Eberhard-Karls University Tübingen, Germany
![Loading Loading](https://www.medrxiv.org/sites/all/modules/contrib/panels_ajax_tab/images/loading.gif)
Article usage
Posted October 14, 2020.
Pathophysiology-based subphenotyping of individuals at elevated risk for type 2 diabetes
Robert Wagner, Martin Heni, Adam G. Tabak, Jürgen Machann, Fritz Schick, Elko Randrianarisoa, Martin Hrabě de Angelis, Andreas L. Birkenfeld, Norbert Stefan, Andreas Peter, Hans-Ulrich Häring, Andreas Fritsche
medRxiv 2020.10.12.20210062; doi: https://doi.org/10.1101/2020.10.12.20210062
Pathophysiology-based subphenotyping of individuals at elevated risk for type 2 diabetes
Robert Wagner, Martin Heni, Adam G. Tabak, Jürgen Machann, Fritz Schick, Elko Randrianarisoa, Martin Hrabě de Angelis, Andreas L. Birkenfeld, Norbert Stefan, Andreas Peter, Hans-Ulrich Häring, Andreas Fritsche
medRxiv 2020.10.12.20210062; doi: https://doi.org/10.1101/2020.10.12.20210062
Subject Areas
- Addiction Medicine (342)
- Allergy and Immunology (665)
- Anesthesia (180)
- Cardiovascular Medicine (2625)
- Dermatology (222)
- Emergency Medicine (397)
- Epidemiology (12175)
- Forensic Medicine (10)
- Gastroenterology (756)
- Genetic and Genomic Medicine (4064)
- Geriatric Medicine (385)
- Health Economics (676)
- Health Informatics (2625)
- Health Policy (997)
- Hematology (360)
- HIV/AIDS (845)
- Medical Education (398)
- Medical Ethics (109)
- Nephrology (430)
- Neurology (3832)
- Nursing (209)
- Nutrition (570)
- Oncology (2008)
- Ophthalmology (581)
- Orthopedics (238)
- Otolaryngology (304)
- Pain Medicine (250)
- Palliative Medicine (73)
- Pathology (471)
- Pediatrics (1107)
- Primary Care Research (447)
- Public and Global Health (6499)
- Radiology and Imaging (1390)
- Respiratory Medicine (869)
- Rheumatology (400)
- Sports Medicine (338)
- Surgery (441)
- Toxicology (52)
- Transplantation (185)
- Urology (165)